All In MedTech

FDA Clearance Tracker · P130021

MEDTRONIC COREVALVE SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jan 17, 2014 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jan 17, 2014

Approved

Time to decision

179 days

Received Jul 22, 2013. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P130021
Device name
MEDTRONIC COREVALVE SYSTEM
Applicant location
Miinneapolis, MN
Received
Jul 22, 2013
Decided
Jan 17, 2014
Decision
Approved
Supplements
183 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NPT

FDA's approval statement

As written in FDA's record.

Approval for the Medtronic CoreValve™ System. This device is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis (aortic valve area ? 0.8 cm2, a mean aortic valve gradient of > 40 mmHg, or a peak aortic-jet velocity of > 4.0 m/s) and with native aortic annulus diameters between 18 and 29 mm who are judged by a heart team, including a cardiac surgeon, to be at extreme risk or inoperable for open surgical therapy (predicted risk of operative mortality and/or serious irreversible morbidity ? 50% at 30 days).

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NPT. The earliest in FDA's data is P100041, decided Nov 2, 2011.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.